SCHEMBL198976

SCHEMBL198976

CCCC[CH]SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL198868 0.91
SCHEMBL198829 0.88 TSHR (0.48)
SCHEMBL199322 0.88 TSHR (0.48)
SCHEMBL200480 0.88 TSHR (0.48)
SCHEMBL200934 0.88
SCHEMBL198695 0.88 TSHR (0.48)
SCHEMBL387241 0.88 TSHR (0.48)
SCHEMBL198939 0.88 TSHR (0.48)
SCHEMBL199242 0.88 TSHR (0.48)
SCHEMBL200469 0.88 TSHR (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049543-B1 ACYCLIC AMINE INHIBITORS OF 5'-METHYLTHIOADENOSINE PHOSPHORYLASE AND NUCLEOSIDASE CALLAGHAN INNOVATION RES LTD (NZ) 2014-11-05 EP claimed
US-8383636-B2 Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase INDUSTRIAL RESEARCH LIMITED (NZ) 2013-02-26 US claimed
EP-2395005-A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases Industrial Research Limited (NZ) 2011-12-14 EP claimed
EP-2348854-A2 METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING QUORUM SENSING Albert Einstein College Of Medecine Of Yeshiva University (US) 2011-08-03 EP claimed
US-20110130412-A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases BIOCRYST PHARMACEUTICALS, INC. 2011-06-02 US claimed
US-20110046167-A1 ACYCLIC AMINE INHIBITORS OF 5-METHYTIOADENOSINE PHOSPHORYLASE AND NUCLEOSIDASE ALBERT EINSTEIN COLLEGE OF MEDICINE 2011-02-24 US claimed
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP claimed
WO-2010033236-A2 METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING QUORUM SENSING ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2010-03-25 WO claimed
WO-2008030119-A9 ACYCLIC AMINE INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND HYDROLASES INDUSTRIAL RESEARCH LIMITED (NZ) 2009-09-24 WO claimed
EP-2057165-A1 ACYCLIC AMINE INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND HYDROLASES INDUSTRIAL RESEARCH LIMITED (NZ) 2009-05-13 EP claimed
WO-2008030118-A1 ACYCLIC AMINE INHIBITORS OF 5'-METHYLTHIOADENOSINE PHOSPHORYLASE AND NUCLEOSIDASE INDUSTRIAL RESEARCH LIMITED (NZ) 2008-03-13 WO claimed
WO-2008030119-A1 ACYCLIC AMINE INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND HYDROLASES INDUSTRIAL RESEARCH LIMITED (NZ) 2008-03-13 WO claimed
EP-1893184-A2 ORAL DOSAGE FORM COMPRISING AN ANTIMISUSE SYSTEM Flamel Technologies (FR) 2008-03-05 EP claimed
US-20080008659-A1 Oral dosage form comprising an antimisuse system FLAMEL TECHNOLOGIES (FR) 2008-01-10 US claimed
WO-2007135193-A2 SUSTAINED-RELEASE ALCOHOL-RESISTANT MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM COMPRISING ANTI-MISUSE MEANS FLAMEL TECHNOLOGIES (FR) 2007-11-29 WO claimed
WO-2007054378-A1 ANTI-MISUSE MICROPARTICULATE ORAL PHARMACEUTICAL FORM FLAMEL TECHNOLOGIES (FR) 2007-05-18 WO claimed
WO-2006133733-A1 ORAL DOSAGE FORM COMPRISING AN ANTIMISUSE SYSTEM FLAMEL TECHNOLOGIES (FR) 2006-12-21 WO claimed
WO-2006134018-A2 ORAL DOSAGE FORM COMPRISING AN ANTIMISUSE SYSTEM FLAMEL TECHNOLOGIES (FR) 2006-12-21 WO claimed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US claimed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US claimed